NuSil Technology LLC recently announced the appointment of Ernest Waaser as its new CEO. Waaser brings more than 30 years of experience in leading numerous public and privately held healthcare companies. He takes over from NuSil’s co-founder and CEO, Dick Compton, who is retiring as CEO but will continue to serve as chairman of the Board of Directors.
Prior to NuSil, Waaser was an operating partner at Linden Capital Partners; previous to that, he served as CEO of Systagenix Wound Management, a private equity-backed spinout of Johnson & Johnson’s advanced wound care unit, where he led the business through a period of growth resulting in a sale to Kinetic Concepts Inc.